Verwendung eines Suspensionsmediums für rote Blutkörperchen

European patent · EP1869977 · In force

Register entry

Publication number
EP1869977
Application number
EP07380137
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 14, 2007
Published
Dec 26, 2007
Granted
Apr 29, 2015
Protection ends at the latest
May 13, 2027
Next annual fee due
May 31, 2027
IPC classes
A01N 1/02 (2006.01)
A61K 35/14 (2015.01)
A61K 35/18 (2015.01)
G01N 33/80 (2006.01)
G01N 33/96 (2006.01)
Priority
ES 200601682 22.06.2006
Filing language
Spanish
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Jun 16, 2015

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 16.06.2015

  6. Apr 29, 2015

    Granted

    Published in Swissreg on 29.04.2015

Parties

Holder

GRIFOLS, S.A.

Grifols, S.A.

C/Jesús y María, 6, 08022 Barcelona, ES

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

Martorell Pena, Daniel

08034 Barcelona, ES

Través Polo, Mª del Carmen

08031 Barcelona, ES

Farré León, Jordi

08224 Terrassa (Barcelona), ES

Castells Parera, Josefina

08530 La Garriga (Barcelona), ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.